Abstract
Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have